Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Dusa updates Levulan PDT development

Oct. 18, 1999

Idec commences phase I/II study with IDEC-114 for treatment of psoriasis

Oct. 7, 1999

BMS and Gillette seek approval for Vaniqa in the U.S.

Oct. 7, 1999

Abgenix completes phase I/II clinical trial with ABX-IL-8

Oct. 6, 1999

Antiallergic agents described by Senju in recently issued patent

Sep. 30, 1999

Results of phase III becaplermin study in pressure ulcers are inconsistent with phase II findings

Sep. 29, 1999

Roche presents antiproliferative retiferol derivatives particularly useful for psoriasis

Sep. 29, 1999

Kanebo discloses preparation and use of new selectin inhibitors

Sep. 27, 1999

Switch Biotech awarded grant for wound-healing therapies

Sep. 21, 1999

CXCR1/CXCR2 receptor antagonists a focus of research at Warner-Lambert

Sep. 17, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...